CIN Newsroom

Will the cannabis sector finally convert analyst optimism into price momentum, or will macro resistance keep conviction locked in the footnotes?

Read the full US brief for 2026-07-26.

Can the cannabis sector break out of its three-week range without a macro catalyst, or is this week simply a test of patience before the next earnings wave arrives in August?

Read the full US brief for 2026-07-26.

CIN Newsroom — 2026-07-23

The daily audio brief for institutional cannabis investors. MSO earnings, distressed cannabis names, capital markets, and the numbers behind the news.

Method: Generated from the live CIN Newsroom tape at cin-newsroom.pplx.app. Freshness bucketing, mover selection, and issuer status are computed from the same tape that powers the CanIDeal terminal.

Cannabis Investor News is editorial. CanIDeal is the commodities terminal it reports from.

Trump rescheduling chatter flooded cannabis micro-caps Wednesday, but institutional-grade MSO names barely moved—and that divergence is the story heading into tomorrow's open.

Read the full US brief for 2026-07-22.

Ascend Wellness pushed forward with uplisting plans today, but the multistate-operator complex paid no attention — and that's the headline.

Read the full US brief for 2026-07-21.

CIN Newsroom — 2026-07-21

The daily audio brief for institutional cannabis investors. MSO earnings, distressed cannabis names, capital markets, and the numbers behind the news.

Method: Generated from the live CIN Newsroom tape at cin-newsroom.pplx.app. Freshness bucketing, mover selection, and issuer status are computed from the same tape that powers the CanIDeal terminal.

Cannabis Investor News is editorial. CanIDeal is the commodities terminal it reports from.

Cannabis equity markets open Tuesday facing a structural question masked by surface calm: whether multi-state operator uplisting momentum represents genuine institutional on-ramps or simply the final stage of a regulatory narrative that has already been discounted.

Read the full US brief for 2026-07-21.

Will cannabis equities finally break their range, or does the July calendar vacuum guarantee another week of drift?

Read the full US brief for 2026-07-19.

Will venue arbitrage or earnings silence define cannabis returns in the week ahead?

Read the full US brief for 2026-07-19.

CIN Newsroom — 2026-07-15

The daily audio brief for institutional cannabis investors. MSO earnings, distressed cannabis names, capital markets, and the numbers behind the news.

Method: Generated from the live CIN Newsroom tape at cin-newsroom.pplx.app. Freshness bucketing, mover selection, and issuer status are computed from the same tape that powers the CanIDeal terminal.

Cannabis Investor News is editorial. CanIDeal is the commodities terminal it reports from.

Trulieve's NYSE debut lifted ancillary suppliers and fertilizer plays by mid-single digits while multi-state operators drifted or sold off, exposing a liquidity gap that persists even after the first exchange uplist under the Trump administration's cancer-research carveout.

Read the full US brief for 2026-07-13.

Trulieve's NYSE debut has created a two-tier cannabis market, with ancillary suppliers jumping while multi-state operators fade, and no clear crossover catalyst emerging for broader plant-touching equities into Monday's open.

Read the full US brief for 2026-07-13.

CIN Newsroom — 2026-07-13

The daily audio brief for institutional cannabis investors. MSO earnings, distressed cannabis names, capital markets, and the numbers behind the news.

Method: Generated from the live CIN Newsroom tape at cin-newsroom.pplx.app. Freshness bucketing, mover selection, and issuer status are computed from the same tape that powers the CanIDeal terminal.

Cannabis Investor News is editorial. CanIDeal is the commodities terminal it reports from.

Will Trulieve's NYSE debut prove to be the sector inflection point or another false signal buried by rangebound drift?

Read the full US brief for 2026-07-12.

CytRx spiked three hundred twenty-nine percent on cannabinoid receptor trial data in a session that split cannabis equities cleanly down the middle: biotech plays with IP optionality found air while the core MSO cohort sat range-bound, waiting for regulatory clarity that still hasn't arrived.

Read the full US brief for 2026-07-10.

Cannabis equities open Thursday with breadth in expansion mode but no single catalyst large enough to drive conviction, as the sector waits for either SAFE Banking passage or final DEA guidance on Schedule III to break the range that has defined tape action for the past six weeks.

Read the full US brief for 2026-07-10.

Trulieve's NYSE debut on Tuesday split the cannabis tape in two — ancillary suppliers surged on crossover hope while multi-state operators drifted, exposing a liquidity gap that persists even after the first CSA-compliant uplist.

Read the full US brief for 2026-07-09.

Cannabis equity markets open Thursday facing a fundamental question: whether Trulieve's NYSE debut marks a sector-wide uplisting wave or a regulatory one-off, after ancillary stocks surged while multi-state operators drifted through Wednesday's session.

Read the full US brief for 2026-07-09.

CIN Newsroom — 2026-07-09

The daily audio brief for institutional cannabis investors. MSO earnings, distressed cannabis names, capital markets, and the numbers behind the news.

Method: Generated from the live CIN Newsroom tape at cin-newsroom.pplx.app. Freshness bucketing, mover selection, and issuer status are computed from the same tape that powers the CanIDeal terminal.

Cannabis Investor News is editorial. CanIDeal is the commodities terminal it reports from.

Trulieve's historic NYSE listing triggered a seven-percent surge in ancillary suppliers yesterday, but multi-state operators sold off, exposing a liquidity bifurcation that leaves the broader sector still tethered to over-the-counter trading and cautious institutional flows.

Read the full US brief for 2026-07-08.

CIN Newsroom — 2026-07-08

The daily audio brief for institutional cannabis investors. MSO earnings, distressed cannabis names, capital markets, and the numbers behind the news.

Method: Generated from the live CIN Newsroom tape at cin-newsroom.pplx.app. Freshness bucketing, mover selection, and issuer status are computed from the same tape that powers the CanIDeal terminal.

Cannabis Investor News is editorial. CanIDeal is the commodities terminal it reports from.

Trulieve's NYSE debut triggered a seven-point-nine-five percent spike in Scotts Miracle-Gro on Tuesday but left peer multi-state operators flat or lower, exposing a liquidity gap that persists even after the first CSA-compliant uplist and suggesting the market views the approval as a one-off regulatory accommodation rather than a sector-wide green light.

Read the full US brief for 2026-07-07.

Cannabis traders face a bifurcated market into Monday's open: Trulieve's historic NYSE listing has turbocharged ancillary suppliers while leaving multi-state operators flat or lower, exposing a structural liquidity gap that persists even after the sector's first CSA-compliant uplist.

Read the full US brief for 2026-07-06.

Five Before the Bell — The Week Ahead is the CIN Newsroom's Sunday-morning look at the cannabis tape. Macro overview plus five actionable items for when the Monday bell rings.

Debut episode. New Sunday show launches this week and drops every Sunday morning going forward, before US markets open.

What we cover this week